Condition
Ampullary Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Ampullary Adenocarcinoma clinical trials that are recruiting, at sites in 3 countries (most in France (2), United States (2), Italy (1)). By phase: Phase 3 (1), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Ampullary Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Hepatic artery infusion therapy for liver metastases after pancreatic/duodenal cancer surgery | — | Orlando, Florida | Recruiting | Sep 29, 2026 |
| Planned surgery or focused local treatment after chemo for metastatic upper-GI adenocarcinoma with undetectable ctDNA | Phase 2 | New Haven, Connecticut | Recruiting | Dec 15, 2025 |
| Adjuvant mFOLFIRINOX versus capecitabine or gemcitabine for resected ampullary adenocarcinoma | Phase 3 | Dijon | Recruiting | Feb 7, 2025 |
| Adjuvant chemotherapy for ampullary cancer after surgery | — | Brescia, BS | Recruiting | Oct 5, 2023 |
| Total pancreatectomy with islet autotransplantation for cancers in the pancreatic head at high risk of postoperative fistula | Phase 1/2 | Lille | Recruiting | Nov 10, 2021 |
All recruiting trials (5)
-
Hepatic artery infusion therapy for liver metastases after pancreatic/duodenal cancer surgery
This study tests whether delivering chemotherapy directly to the liver via a pump can help people with pancreatic or duodenal cancer that has spread mainly to the liver after surgery and prior chemotherapy.
-
Planned surgery or focused local treatment after chemo for metastatic upper-GI adenocarcinoma with undetectable ctDNA
This test sees if adding planned surgery or local treatments after three months of chemotherapy helps people with metastatic upper-gastrointestinal adenocarcinomas who have undetectable ctDNA.
-
Adjuvant mFOLFIRINOX versus capecitabine or gemcitabine for resected ampullary adenocarcinoma
This trial will test whether giving modified FOLFIRINOX after surgery lowers the chance of cancer returning compared with capecitabine or gemcitabine in adults with resected ampullary adenocarcinoma.
-
Adjuvant chemotherapy for ampullary cancer after surgery
This study is testing if personalized chemotherapy after surgery can help people with ampullary cancer live longer and feel better, based on their specific tumor type.
-
Total pancreatectomy with islet autotransplantation for cancers in the pancreatic head at high risk of postoperative fistula
This trial tests whether removing the whole pancreas and immediately transplanting the patient's own insulin-producing cells into the liver helps people with resectable cancers of the pancreatic head, duodenum, or ampulla who are at high risk for dangerous post-surgery pancreatic leaks.
Related topics
Quick answers
How many Ampullary Adenocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (2 trials), United States (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.